Table 2.2.
Frequency and Costs of Claims for Gender-Affirming Hormone Therapy, 1993-2019
| Testosterone | Estrogens + Anti-Androgens | GnRH | All Combined | |
|---|---|---|---|---|
| Overall frequency | 5,522 | 6,403 | 51 | 11,976 |
| Percent of hormone therapy users | 46.1 | 53.5 | 0.43 | - |
| Percent of total transgender population (N = 16,619) | 33.2 | 38.5 | 0.31 | 72.1 |
| Average time in coverage (years) | 4.5 | 4.8 | 6.8 | - |
| Health plan paid costs, $ | ||||
| Per person | 545 | 735 | 16,385 | 515* |
| Per year of coverage | 121 | 153 | 2,410 | 107* |
| Out-of-pocket costs, $ | ||||
| Per person | 178 | 458 | 1,453 | 240* |
| Per year of coverage | 40 | 95 | 214 | 51* |
| Total costs, $ | ||||
| Per person | 723 | 1,193 | 17,838 | 755* |
| Per year of coverage | 161 | 248 | 2,623 | 157* |
| Out-of-pocket proportion, % | 25 | 38 | 8 | 32 |
GnRH = gonadotropin-releasing hormone
* Average weighted by proportion of people with prescriptions for each type of therapy; denominator is the total number of transgender people identified in OLDW (N = 16,619)